Diastrophic dysplasia
Diastrophic dysplasia is a rare autosomal recessive disorder that affects the development of cartilage and bone. It is characterized by dwarfism, spinal deformities, and abnormalities in the hands and feet.
Genetics
Diastrophic dysplasia is caused by mutations in the SLC26A2 gene, which provides instructions for making a protein involved in the development of cartilage and bone. The condition follows an autosomal recessive inheritance pattern, meaning that an affected individual must inherit two copies of the mutated gene, one from each parent.
Clinical Features
Individuals with diastrophic dysplasia typically present with short stature due to shortened limbs, scoliosis or other spinal deformities, and joint contractures. The hands often exhibit a characteristic "hitchhiker thumb" due to a specific type of thumb deformity. Cleft palate and ear abnormalities, such as cystic ear swelling, are also common.
Diagnosis
Diagnosis of diastrophic dysplasia is based on clinical evaluation, characteristic radiological findings, and genetic testing to identify mutations in the SLC26A2 gene. Prenatal diagnosis is possible through amniocentesis or chorionic villus sampling if there is a known risk of the disorder.
Management
There is no cure for diastrophic dysplasia, but treatment focuses on managing symptoms and improving quality of life. This may include physical therapy, orthopedic surgery to correct skeletal deformities, and occupational therapy to assist with daily activities. Regular monitoring by a multidisciplinary team is essential to address the various health issues that may arise.
Prognosis
The prognosis for individuals with diastrophic dysplasia varies. While the condition is associated with significant physical challenges, many individuals lead fulfilling lives with appropriate medical care and support. Life expectancy is generally normal, although complications related to spinal deformities and respiratory issues can occur.
Related Pages
-
Diastrophic dysplasia
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Special offer:
Budget GLP-1 weight loss medications
- Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
- Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay
✔ Same-week appointments, evenings & weekends
Learn more:
- GLP-1 weight loss clinic NYC
- W8MD's NYC medical weight loss
- W8MD Philadelphia GLP-1 shots
- Philadelphia GLP-1 injections
- Affordable GLP-1 shots NYC
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian